{
    "organizations": [],
    "uuid": "c98baac33659d1a7ffa3b6e1bb80729244b4ae01",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-tasly-pharmas-unit-signs-licensing/brief-tasly-pharmas-unit-signs-licensing-agreement-on-diabetes-medicine-with-eli-lilly-idUSH9N1RB02L",
    "ord_in_thread": 0,
    "title": "BRIEF-Tasly Pharma's Unit Signs Licensing Agreement On Diabetes Medicine With Eli Lilly",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 3 (Reuters) - Tasly Pharmaceutical Group Co Ltd :\n* SAYS UNIT SIGNS LICENSING AGREEMENT ON DIABETES MEDICINE WITH ELI LILLY Source text in Chinese: bit.ly/2EfkbCp Further company coverage: (Reporting by Hong Kong newsroom)\n ",
    "published": "2018-04-03T15:51:00.000+03:00",
    "crawled": "2018-04-03T11:35:23.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "tasly",
        "pharmaceutical",
        "group",
        "co",
        "ltd",
        "say",
        "unit",
        "sign",
        "licensing",
        "agreement",
        "diabetes",
        "medicine",
        "eli",
        "lilly",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "reporting",
        "hong",
        "kong",
        "newsroom"
    ]
}